58
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of a checklist of information to include in publications describing in vivo experiments to enable others to scrutinise the work adequately, evaluate its methodological rigour, and reproduce the methods and results. Despite considerable levels of endorsement by funders and journals over the years, adherence to the guidelines has been inconsistent, and the anticipated improvements in the quality of reporting in animal research publications have not been achieved. Here, we introduce ARRIVE 2.0. The guidelines have been updated and information reorganised to facilitate their use in practice. We used a Delphi exercise to prioritise and divide the items of the guidelines into 2 sets, the “ARRIVE Essential 10,” which constitutes the minimum requirement, and the “Recommended Set,” which describes the research context. This division facilitates improved reporting of animal research by supporting a stepwise approach to implementation. This helps journal editors and reviewers verify that the most important items are being reported in manuscripts. We have also developed the accompanying Explanation and Elaboration (E&E) document, which serves (1) to explain the rationale behind each item in the guidelines, (2) to clarify key concepts, and (3) to provide illustrative examples. We aim, through these changes, to help ensure that researchers, reviewers, and journal editors are better equipped to improve the rigour and transparency of the scientific process and thus reproducibility.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

          Improving the reproducibility of biomedical research is a major challenge. Transparent and accurate reporting is vital to this process; it allows readers to assess the reliability of the findings and repeat or build upon the work of other researchers. The ARRIVE guidelines (Animal Research: Reporting In Vivo Experiments) were developed in 2010 to help authors and journals identify the minimum information necessary to report in publications describing in vivo experiments. Despite widespread endorsement by the scientific community, the impact of ARRIVE on the transparency of reporting in animal research publications has been limited. We have revised the ARRIVE guidelines to update them and facilitate their use in practice. The revised guidelines are published alongside this paper. This explanation and elaboration document was developed as part of the revision. It provides further information about each of the 21 items in ARRIVE 2.0, including the rationale and supporting evidence for their inclusion in the guidelines, elaboration of details to report, and examples of good reporting from the published literature. This document also covers advice and best practice in the design and conduct of animal studies to support researchers in improving standards from the start of the experimental design process through to publication.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.

            This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A call for transparent reporting to optimize the predictive value of preclinical research.

              The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.
                Bookmark

                Author and article information

                Contributors
                info@bps.ac.uk
                Journal
                Br J Pharmacol
                Br. J. Pharmacol
                10.1111/(ISSN)1476-5381
                BPH
                British Journal of Pharmacology
                John Wiley and Sons Inc. (Hoboken )
                0007-1188
                1476-5381
                14 July 2020
                August 2020
                14 July 2020
                : 177
                : 16 ( doiID: 10.1111/bph.v177.16 )
                : 3617-3624
                Affiliations
                [ 1 ] NC3Rs London UK
                [ 2 ] The William Harvey Research Institute London UK
                [ 3 ] Barts Cardiovascular CTU Queen Mary University of London London UK
                [ 4 ] Taylor & Francis Group London UK
                [ 5 ] Health Science Practice, ICF, Durham North Carolina USA
                [ 6 ] Nature, San Francisco California USA
                [ 7 ] School of Education University of Bristol Bristol UK
                [ 8 ] PLOS ONE Cambridge UK
                [ 9 ] School of Biological Sciences University of Bristol Bristol UK
                [ 10 ] QUEST Center for Transforming Biomedical Research, Berlin Institute of Health & Department of Experimental Neurology Charite Universitätsmedizin Berlin Berlin Germany
                [ 11 ] National Heart and Lung Institute Imperial College London London UK
                [ 12 ] Centre for Evidence Synthesis in Global Health, Clinical Sciences Department Liverpool School of Tropical Medicine Liverpool UK
                [ 13 ] Clinical and Experimental Sciences University of Southampton Southampton UK
                [ 14 ] Tasmanian School of Medicine University of Tasmania Hobart Australia
                [ 15 ] Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca Cambridge UK
                [ 16 ] Prioris.ai Inc Ottawa Canada
                [ 17 ] Hindawi Ltd London UK
                [ 18 ] University of Edinburgh Edinburgh UK
                [ 19 ] Academia Europaea Knowledge Hub Cardiff University Cardiff UK
                [ 20 ] Medical Research Council London UK
                [ 21 ] Statistics in Anesthesiology Research (STAR) Core & Research Assistant Professor, Department of Anesthesiology College of Medicine, University of Florida, Gainesville Florida USA
                [ 22 ] Discipline of Exercise and Sport Science, Faculty of Medicine and Health University of Sydney Sydney Australia
                [ 23 ] National Institute of Neurological Disorders and Stroke Bethesda Maryland USA
                [ 24 ] Janssen Pharmaceutica NV Beerse Belgium
                [ 25 ] Veterinary Public Health Institute, Vetsuisse Faculty University of Bern Bern Switzerland
                Author notes
                [*] [* ] Correspondence

                Amrita Ahluwalia, British Journal of Pharmacology, The Schild Plot, 16 Angel Gate, City Road. London EC1V 2PT, UK.

                Email: info@ 123456bps.ac.uk

                Article
                BPH15193
                10.1111/bph.15193
                7393194
                32662519
                66dc1ca7-c996-4ec1-b4ac-4da0261e1262
                © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 0, Tables: 2, Pages: 3624, Words: 7442
                Categories
                Perspective
                Perspective
                Custom metadata
                2.0
                August 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:30.07.2020

                Pharmacology & Pharmaceutical medicine
                Pharmacology & Pharmaceutical medicine

                Comments

                Comment on this article